Onconic Therapeutics Inc.
Biopharmaceutical company developing drugs for cancer and gastrointestinal disorders.
476060 | KO
Overview
Corporate Details
- ISIN(s):
- KR7476060009
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 테헤란로26길 12 제일비젼타워 11층, 강남구
- Website:
- http://onconic.co.kr/
- Sector:
- Manufacturing
Description
Onconic Therapeutics Inc., established in 2020, is a biopharmaceutical company specializing in the research and development of innovative drugs. A subsidiary of Jeil Pharmaceutical, the company focuses on creating novel treatments for cancer and gastrointestinal disorders, including gastroesophageal reflux disease. Its development strategy prioritizes therapeutics for conditions with high unmet medical needs and significant market potential. Onconic Therapeutics actively advances its pipeline of drug candidates through various stages of clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-17 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (네수파립의 위암 제1b/2상 임상시험계획승인(변경승인))
|
Korean | 13.0 KB | ||
| 2025-09-17 00:00 |
주권매매거래정지 (무상증자)
|
Korean | 4.8 KB | ||
| 2025-09-17 00:00 |
주요사항보고서(무상증자결정)
|
Korean | 10.2 KB | ||
| 2025-09-15 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (자큐보정(JP1366)(자스타프라잔시트르산염)의 약물상호작용 확인을 위한…
|
Korean | 11.6 KB | ||
| 2025-09-05 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-09-01 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-08-22 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-08-19 00:00 |
투자판단관련주요경영사항 (파트너사인 Livzon Pharmaceutical Group Inc.에 Zastaprazan(…
|
Korean | 10.4 KB | ||
| 2025-08-18 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청) (네수파립의 췌장암 제1b/2상 임상시험계획승인(변경승인)신청))
|
Korean | 10.7 KB | ||
| 2025-08-11 00:00 |
반기보고서 (2025.06)
|
Korean | 929.6 KB | ||
| 2025-08-01 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청) (자큐보정 JP-1366 약물상호작용 확인을 위한 1상 임상시험계획승인…
|
Korean | 10.7 KB | ||
| 2025-07-30 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청) (네수파립의 위암 제1b/w상 임상시험계획승인(변경승인)신청)
|
Korean | 11.5 KB | ||
| 2025-07-30 00:00 |
[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (네수파립의 위암 제1b/2상 임상시험계획승인(변경승인)신청)
|
Korean | 14.7 KB | ||
| 2025-07-02 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (자큐보정(JP-1366)(자스타프라잔시트르산염)의 비미란성 위식도역류질환…
|
Korean | 11.3 KB | ||
| 2025-06-17 00:00 |
투자판단관련주요경영사항 (국산신약 37호 자큐보정의 품목허가사항 변경허가 승인(위궤양 신규적응증 추가를 위한 한국 식품…
|
Korean | 7.7 KB |
Automate Your Workflow. Get a real-time feed of all Onconic Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Onconic Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Onconic Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
